SG11201901228QA - Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide - Google Patents
Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptideInfo
- Publication number
- SG11201901228QA SG11201901228QA SG11201901228QA SG11201901228QA SG11201901228QA SG 11201901228Q A SG11201901228Q A SG 11201901228QA SG 11201901228Q A SG11201901228Q A SG 11201901228QA SG 11201901228Q A SG11201901228Q A SG 11201901228QA SG 11201901228Q A SG11201901228Q A SG 11201901228QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- ionic surfactant
- polypeptide
- san francisco
- south san
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3847—Multimodal interactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662375373P | 2016-08-15 | 2016-08-15 | |
| PCT/US2017/046725 WO2018035025A1 (fr) | 2016-08-15 | 2017-08-14 | Procédé de chromatographie destiné à quantifier un tensioactif non ionique dans une composition comprenant le tensioactif non ionique et un polypeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201901228QA true SG11201901228QA (en) | 2019-03-28 |
Family
ID=59687053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201901228QA SG11201901228QA (en) | 2016-08-15 | 2017-08-14 | Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11333644B2 (fr) |
| EP (1) | EP3497440A1 (fr) |
| JP (1) | JP7286536B2 (fr) |
| KR (1) | KR102617148B1 (fr) |
| CN (2) | CN115598231A (fr) |
| AR (1) | AR109343A1 (fr) |
| AU (2) | AU2017312540B2 (fr) |
| BR (1) | BR112019002979B1 (fr) |
| CA (1) | CA3033737A1 (fr) |
| IL (1) | IL264582B (fr) |
| MX (1) | MX2019001572A (fr) |
| SG (1) | SG11201901228QA (fr) |
| TW (1) | TWI775770B (fr) |
| WO (1) | WO2018035025A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210139387A1 (en) * | 2016-01-19 | 2021-05-13 | Genebiologics, Llc | Production of Arginine-Rich Proteins from Wastewater and Use as a Fertilizer |
| EP3497440A1 (fr) | 2016-08-15 | 2019-06-19 | H. Hoffnabb-La Roche Ag | Procédé de chromatographie destiné à quantifier un tensioactif non ionique dans une composition comprenant le tensioactif non ionique et un polypeptide |
| TW202045927A (zh) * | 2019-02-27 | 2020-12-16 | 法商賽諾菲公司 | 以具內標之lc-ms於樣品中進行聚山梨醇酯定量之方法 |
| CN113424057B (zh) * | 2019-04-19 | 2024-04-05 | 海正生物制药有限公司 | 组合物中泊洛沙姆188的检测方法 |
| CA3137116A1 (fr) | 2019-05-03 | 2020-11-12 | Genentech, Inc. | Procedes de reduction du taux d'activite d'hydrolyse enzymatique dans une composition obtenue a partir d'une plateforme de purification |
| CA3198684A1 (fr) | 2020-10-30 | 2022-05-05 | Genentech, Inc. | Plateformes de purification pour obtenir des compositions pharmaceutiques ayant un taux d'activite d'hydrolyse enzymatique reduit |
| WO2022179970A1 (fr) | 2021-02-24 | 2022-09-01 | F. Hoffmann-La Roche Ag | Régénération et utilisation multiple de filtres en profondeur |
| KR102283871B1 (ko) * | 2021-03-02 | 2021-08-02 | 한국원자력연구원 | 크로마토그래피를 이용한 무담체 홀뮴-166의 분리 방법, 분리 장치 및 이에 의하여 분리된 무담체 홀뮴-166 |
| WO2023126903A2 (fr) * | 2021-12-31 | 2023-07-06 | Kashiv Biosciences, Llc | Procédé de séparation et de quantification d'un tensioactif non ionique |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| EP0308936B1 (fr) | 1987-09-23 | 1994-07-06 | Bristol-Myers Squibb Company | Hétéroconjugués d'anticorps pour tuer des cellules infectées par VIH |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| ES2096590T3 (es) | 1989-06-29 | 1997-03-16 | Medarex Inc | Reactivos biespecificos para la terapia del sida. |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| WO1992020373A1 (fr) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Anticorps d'heteroconjugues pour le traitement des infections a l'hiv |
| JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
| IE922437A1 (en) | 1991-07-25 | 1993-01-27 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| JP3951062B2 (ja) | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、２官能性Ｆ（ａｂ’）２抗体の産生のための使用 |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
| WO1993008829A1 (fr) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions induisant la destruction de cellules infectees par l'hiv |
| EP0617706B1 (fr) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Proteines multivalentes de fixation aux antigenes |
| WO1993016185A2 (fr) | 1992-02-06 | 1993-08-19 | Creative Biomolecules, Inc. | Proteine de liaison biosynthetique pour marqueur de cancer |
| EP0626012B1 (fr) | 1992-02-11 | 2003-07-09 | Cell Genesys, Inc. | Obtention d'homozygotes par ciblage de genes |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| EP0656064B1 (fr) | 1992-08-17 | 1997-03-05 | Genentech, Inc. | Immunoadhesines bispecifiques |
| RO118524B1 (ro) | 1992-11-13 | 2003-06-30 | Idec Pharmaceuticals Corp San | Metoda pentru tratarea unei tulburari legata de celulele b |
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5712374A (en) | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| JPH0943218A (ja) * | 1995-08-04 | 1997-02-14 | Kao Corp | 非イオン界面活性剤の分析方法 |
| AU3454899A (en) * | 1998-03-30 | 1999-10-18 | Cell Therapeutics, Inc. | Methods of separation and detection |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US8372954B2 (en) | 2000-12-22 | 2013-02-12 | National Research Council Of Canada | Phage display libraries of human VH fragments |
| JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
| GB0310347D0 (en) * | 2003-05-07 | 2003-06-11 | Delta Biotechnology Ltd | Assay |
| SI1639011T1 (sl) | 2003-06-30 | 2009-04-30 | Domantis Ltd | Pegilirana protitelesa z enojno domeno (dAb) |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| RU2412947C2 (ru) | 2004-09-23 | 2011-02-27 | Дженентек, Инк. | Антитела, сконструированные на основе цистеинов, и их конъюгаты |
| US7776360B2 (en) * | 2004-12-21 | 2010-08-17 | Baxter International | (Polyalkoxy)sulfonate surface modifiers |
| US7241586B2 (en) * | 2005-02-17 | 2007-07-10 | Medtronic Minimed, Inc. | Polypeptide formulations and methods for making, using and characterizing them |
| JP6151021B2 (ja) | 2009-06-01 | 2017-06-21 | ウオーターズ・テクノロジーズ・コーポレイシヨン | クロマトグラフ分離用ハイブリッド材料 |
| US20120294866A1 (en) * | 2010-01-19 | 2012-11-22 | F. Hoffmann-La Roche Ag | Pharmaceutical formulation for proteins |
| SG10201710439UA (en) * | 2010-05-25 | 2018-01-30 | Genentech Inc | Methods of purifying polypeptides |
| JP5193266B2 (ja) * | 2010-11-16 | 2013-05-08 | 株式会社ミノファーゲン製薬 | 生薬由来成分の高感度定量方法 |
| CN104023804B (zh) * | 2011-11-02 | 2017-05-24 | 弗·哈夫曼-拉罗切有限公司 | 超载和洗脱层析 |
| BR112014029107B1 (pt) * | 2012-05-23 | 2021-07-13 | Glaxosmithkline Biologicals S.A. | Método para determinar a concentração de uma espécie de polissorbato em uma mistura. |
| EP3497440A1 (fr) | 2016-08-15 | 2019-06-19 | H. Hoffnabb-La Roche Ag | Procédé de chromatographie destiné à quantifier un tensioactif non ionique dans une composition comprenant le tensioactif non ionique et un polypeptide |
-
2017
- 2017-08-14 EP EP17755627.1A patent/EP3497440A1/fr active Pending
- 2017-08-14 AU AU2017312540A patent/AU2017312540B2/en active Active
- 2017-08-14 CN CN202210633310.1A patent/CN115598231A/zh active Pending
- 2017-08-14 BR BR112019002979-6A patent/BR112019002979B1/pt active IP Right Grant
- 2017-08-14 CN CN201780057815.5A patent/CN109716127B/zh active Active
- 2017-08-14 KR KR1020197007446A patent/KR102617148B1/ko active IP Right Grant
- 2017-08-14 WO PCT/US2017/046725 patent/WO2018035025A1/fr unknown
- 2017-08-14 MX MX2019001572A patent/MX2019001572A/es unknown
- 2017-08-14 CA CA3033737A patent/CA3033737A1/fr active Pending
- 2017-08-14 JP JP2019507829A patent/JP7286536B2/ja active Active
- 2017-08-14 SG SG11201901228QA patent/SG11201901228QA/en unknown
- 2017-08-15 AR ARP170102272A patent/AR109343A1/es unknown
- 2017-08-15 TW TW106127636A patent/TWI775770B/zh active
-
2019
- 2019-01-31 IL IL264582A patent/IL264582B/en unknown
- 2019-02-14 US US16/275,849 patent/US11333644B2/en active Active
-
2022
- 2022-04-11 US US17/718,162 patent/US11680931B2/en active Active
- 2022-12-21 AU AU2022291517A patent/AU2022291517A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN109716127A (zh) | 2019-05-03 |
| US20230077255A1 (en) | 2023-03-09 |
| AU2022291517A1 (en) | 2023-02-02 |
| US11333644B2 (en) | 2022-05-17 |
| US20190178859A1 (en) | 2019-06-13 |
| KR20190051977A (ko) | 2019-05-15 |
| KR102617148B1 (ko) | 2023-12-26 |
| TW201809658A (zh) | 2018-03-16 |
| EP3497440A1 (fr) | 2019-06-19 |
| CN109716127B (zh) | 2022-06-14 |
| TWI775770B (zh) | 2022-09-01 |
| CA3033737A1 (fr) | 2018-02-22 |
| IL264582B (en) | 2022-04-01 |
| CN115598231A (zh) | 2023-01-13 |
| BR112019002979B1 (pt) | 2023-10-03 |
| WO2018035025A1 (fr) | 2018-02-22 |
| AU2017312540B2 (en) | 2023-02-02 |
| IL264582A (en) | 2019-02-28 |
| US11680931B2 (en) | 2023-06-20 |
| JP7286536B2 (ja) | 2023-06-05 |
| AU2017312540A1 (en) | 2019-02-28 |
| JP2019530857A (ja) | 2019-10-24 |
| MX2019001572A (es) | 2019-08-29 |
| BR112019002979A2 (pt) | 2019-07-09 |
| AR109343A1 (es) | 2018-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901228QA (en) | Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201907056XA (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| SG11201903454VA (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201810023QA (en) | Anti-tim-3 antibodies and methods of use thereof | |
| SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
| SG11201808799SA (en) | Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors | |
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201806322QA (en) | Maytansinoid derivatives, conjugates thereof, and methods of use | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201908420WA (en) | Compositions of plinabulin and use thereof | |
| SG11201807784SA (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201907889YA (en) | Glycan-interacting compounds and methods of use | |
| SG11201907023UA (en) | Method of reducing neutropenia | |
| SG11201810525XA (en) | Anti-gitr antibodies and uses thereof | |
| SG11201901020RA (en) | Anti-siglec-7 antibodies for the treatment of cancer | |
| SG11201810872UA (en) | Composition and method for reducing neutropenia | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201900845YA (en) | Uses of il-13 antagonists for treating atopic dermatitis | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201805755SA (en) | Methods of administering hepcidin |